Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Omepracent 40 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Omepracent 40

Approved

STANDARD

Omepracent 40

Windlas Biotech Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ae042a078cd650d3
Company: Windlas Biotech Limited
Type: Standard

Approval Details

Approval Id: ae042a078cd650d3
Drug Approval Philippines Name: Omepracent 40
Product Name: Omepracent 40
Registration Number: DRP-3016-03
Brand Name: Omepracent 40
Generic Name: Omeprazole
Dosage Form: Capsule
Dosage Strength: 40 mg
Manufacturer: Windlas Biotech Limited
Importer: Grovic Pharma Inc.
Distributor: Central West Medicale Inc.
Company Detail Path: /organization/windlas-biotech-limited
Issuance Date: 11 July 2024
Expiry Date: 02 June 2028
Pharmacologic Category: Proton Pump Inhibitor
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ae042a078cd650d3

Type

Standard

Back to Philippines FDA Approvals